The Role of The Proximal Nephron In Salt-Sensitive Hypertension
近端肾单位在盐敏感性高血压中的作用
基本信息
- 批准号:9197670
- 负责人:
- 金额:$ 47.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-01-01 至 2019-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAffectAgonistAmericanAngiotensin IIAngiotensin-Converting Enzyme InhibitorsAnimalsAtrial Natriuretic FactorBlood PressureCaloriesCardiovascular DiseasesCell membraneChronicConsumptionDataDefectDiabetes MellitusDietDiseaseDominant-Negative MutationDopamineEquilibriumExcretory functionFructoseGene TransferGlucoseHealthHumanHypertensionImageIn VitroIntakeKidneyLiver FailureLosartanMeasuresMediatingMolecular BiologyNa(+)-K(+)-Exchanging ATPaseNatriuresisNephronsNitric OxideNorepinephrinePRKCA genePhlorhizinPhysiologicalPhysiologyProductionProtein IsoformsProtein Kinase CRattusReceptor, Angiotensin, Type 1ReportingRoleSodium ChlorideSuperoxidesTechniquesTestingType 2 Angiotensin II Receptorblood pressure reductiondietary saltexperimental studyfallshigh salt dietin vivoinsightpreventpublic health relevancereceptorresponsesalt sensitivesalt sensitive hypertensionsugarurinary
项目摘要
DESCRIPTION (provided by applicant): Hypertension is the leading cause of "loss of health" worldwide. As much as 50% of hypertension is salt- sensitive, a disease in which blood pressure (BP) increases with dietary salt due to a renal defect. Angiotensin II (Ang II) is a key regulator of BP primarily through actions on the kidney, including the proximal tubule (PT). The PT reabsorbs ~70% of the filtered Na via Na/H exchanger type 3 (NHE3) and Na/K ATPase. Ang II stimulates transport via activation of Ang II type 1 (AT1) receptors and classical protein kinase C (PKC) isoforms (α, β, γ). Physiological concentrations of Ang II when animals are on normal salt maximally stimulate PT Na reabsorption. When dietary salt is elevated, Ang II levels fall by ~70%, urinary Na excretion (UNaV) increases and the salt is eliminated. However, if the effects of Ang II don't decline in the face of a high-salt diet, salt is retained and BP increases.
More than 15 million Americans consume >20% of their calories as fructose. Dietary fructose causes hypertension in humans. We have shown that when rats consume 20% of their calories as fructose (20% fructose diet) they develop salt-sensitive hypertension, and that BP begins to increase 1-2 days after beginning a high-salt diet. AT1 receptor blockers reduce BP in fructose-fed rats; however, the role of the PT and the mechanisms by which fructose causes salt-sensitive hypertension are unknown. We show that fructose can activate PKCα/β in isolated, perfused PTs and that a 20% fructose, high- salt diet enables low concentrations of Ang II to stimulate PT transport measured in vitro, but does not enhance the maximum effect. Atrial natriuretic factor, dopamine, nitric oxide do not play a role. However, whether the effects of fructose on the PT contribute to fructose-induced salt-sensitive hypertension and the mechanisms involved are unknown. We hypothesize that a 20% fructose diet blunts salt-induced natriuresis and causes salt-sensitive hypertension by activating PKCα thereby enabling low concentrations of Ang II such as those caused by a high-salt diet to stimulate PT Na reabsorption. Aim 1 will test whether a 20% fructose diet enables low concentrations of Ang II as caused by a high-salt diet to stimulate PT Na reabsorption by NHE3 and Na/K ATPase. Aim 2 will test whether a 20% fructose diet raises basal PKCα activity thereby enabling low concentrations of Ang II to elevate PKCα activity sufficiently to stimulate Na reabsorption. Aim 3
will test whether the effects of a 20% fructose diet on the PT reduce the ability to excrete a salt
load and cause salt- sensitive hypertension. We will use state of the art techniques in imaging, physiology, molecular biology and gene transfer. This project will yield new insights into how dietary fructose causes salt-sensitive hypertension.
描述(由申请人提供):高血压是全世界“健康损失”的主要原因,多达 50% 的高血压是盐敏感性的,这种疾病是由于肾脏缺陷而导致血压 (BP) 随饮食盐而升高。血管紧张素 II (Ang II) 是血压的关键调节剂,主要通过作用于肾脏,包括近端肾小管 (PT) 来通过 Na/H 交换器重吸收约 70% 的过滤后的 Na。 3 型 (NHE3) 和 Na/K ATP 酶通过激活 Ang II 1 型 (AT1) 受体和经典蛋白激酶 C (PKC) 亚型(α、β、γ)来刺激动物体内 Ang II 的生理浓度。正常盐最大程度地刺激 PT Na 重吸收。当饮食盐升高时,Ang II 水平下降约 70%,尿 Na 排泄 (UNaV) 增加,盐被消除。然而,如果血管紧张素II的作用在高盐饮食中不下降,盐就会被保留,血压就会升高。
超过 1500 万美国人以果糖的形式消耗超过 20% 的热量 膳食果糖会导致人类高血压。我们已经证明,当老鼠以果糖形式消耗 20% 的热量(20% 果糖饮食)时,它们就会患上盐敏感性高血压。开始高盐饮食 1-2 天后血压开始升高,AT1 受体阻滞剂可降低果糖喂养大鼠的血压;然而,PT 和果糖引起盐敏感性高血压的机制尚不清楚,我们发现果糖可以激活分离的灌注 PT 中的 PKCα/β,并且 20% 果糖、高盐饮食可以使低浓度的 Ang II 刺激 PT 转运。体外,但不增强心房钠尿因子,多巴胺、一氧化氮不发挥作用,但果糖是否有助于PT的作用。果糖诱发的盐敏感性高血压及其相关机制尚不清楚,我们认为 20% 果糖饮食会减弱盐诱发的尿钠排泄,并通过激活 PKCα 导致低浓度的 Ang II,例如由高浓度引起的高血压。 -盐饮食刺激 PT Na 重吸收 目标 1 将测试 20% 果糖饮食是否能够像高盐饮食那样导致低浓度的 Ang II 刺激 PT Na。 NHE3 和 Na/K ATP 酶的重吸收 Aim 2 将测试 20% 果糖饮食是否会提高基础 PKCα 活性,从而使低浓度的 Ang II 足以提高 PKCα 活性以刺激 Na 重吸收。
将测试 20% 果糖饮食对 PT 的影响是否会降低排盐能力
我们将利用最先进的成像、生理学、分子生物学和基因转移技术,对膳食果糖如何导致盐敏感性高血压产生新的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey L. Garvin其他文献
Jeffrey L. Garvin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey L. Garvin', 18)}}的其他基金
The role of the proximal nephron in salt-sensitive hypertension
近端肾单位在盐敏感性高血压中的作用
- 批准号:
10321298 - 财政年份:2021
- 资助金额:
$ 47.58万 - 项目类别:
The role of the proximal nephron in salt-sensitive hypertension
近端肾单位在盐敏感性高血压中的作用
- 批准号:
10530623 - 财政年份:2021
- 资助金额:
$ 47.58万 - 项目类别:
The role of the proximal nephron in salt-sensitive hypertension
近端肾单位在盐敏感性高血压中的作用
- 批准号:
10117320 - 财政年份:2021
- 资助金额:
$ 47.58万 - 项目类别:
Regulation of NOS Activity in the Kidney & Hypertension
肾脏中 NOS 活性的调节
- 批准号:
8376980 - 财政年份:2012
- 资助金额:
$ 47.58万 - 项目类别:
Renal Hemodynamics: Mechanisms to Understand Disease
肾脏血流动力学:了解疾病的机制
- 批准号:
7908575 - 财政年份:2010
- 资助金额:
$ 47.58万 - 项目类别:
Regulation of NOS Activity in the Kidney & Hypertension
肾脏中 NOS 活性的调节
- 批准号:
7595338 - 财政年份:2009
- 资助金额:
$ 47.58万 - 项目类别:
Blood Pressure Regulation: Novel Roles for the Kidney
血压调节:肾脏的新作用
- 批准号:
7796788 - 财政年份:2009
- 资助金额:
$ 47.58万 - 项目类别:
相似国自然基金
β2AR激动剂与微秒电刺激对大鼠肛提肌线粒体有氧代谢酶及其多模态影像表型的影响研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
环境激素壬基酚对变应性鼻炎的影响及其对GPER特异性激动剂G-1在变应性鼻炎治疗作用中的干扰机制研究
- 批准号:82000963
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
促生长激素释放激素激动剂抑制平滑肌细胞转分化对动脉粥样硬化的影响及机制研究
- 批准号:81900389
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
五羟色胺2C受体激动剂对2型糖尿病小鼠β细胞功能的影响及机制研究
- 批准号:81803644
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
cAMP信号激动剂对恶性胶质瘤血管新生和血管正常化的影响及机制研究
- 批准号:81803568
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Integrating Tailored Postoperative Opioid Tapering and Pain Management Support for Patients on Long-Term Opioid Use Presenting for Spine Surgery (MIRHIQL)
为脊柱手术中长期使用阿片类药物的患者整合定制的术后阿片类药物逐渐减量和疼痛管理支持 (MIRHIQL)
- 批准号:
10722943 - 财政年份:2023
- 资助金额:
$ 47.58万 - 项目类别:
A Novel Assay to Improve Translation in Analgesic Drug Development
改善镇痛药物开发转化的新方法
- 批准号:
10726834 - 财政年份:2023
- 资助金额:
$ 47.58万 - 项目类别:
Preclinical validation of small molecule immunomodulators for the treatment of Crohn's disease
小分子免疫调节剂治疗克罗恩病的临床前验证
- 批准号:
10600659 - 财政年份:2023
- 资助金额:
$ 47.58万 - 项目类别:
Post-translational Modification of Cx43 Regulates Myometrial Quiescence
Cx43 的翻译后修饰调节子宫肌层静止
- 批准号:
10575364 - 财政年份:2023
- 资助金额:
$ 47.58万 - 项目类别:
Alcohol-induced epigenetic reprogramming of PPAR-α affects allopregnanolone biosynthesis
酒精诱导的 PPAR-α 表观遗传重编程影响异孕酮生物合成
- 批准号:
10658534 - 财政年份:2023
- 资助金额:
$ 47.58万 - 项目类别: